SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers

SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.

13-Aug-2024 - SphingoTec GmbH announces the successful closing of a Series C financing round. The raised capital will allow the company to reach profitability through sustained and strategic commercialization of its products. This includes supporting market development, out-licensing activities, and close ...

Start-up Dynamic42 and Biopredic join for strategic Marketing agreement

New partnership to promote pioneering in vitro systems in drug development

30-Jan-2024 - The organ-on-chip specialist Dynamic42 GmbH and Biopredic, manufacturer of assay systems for research, announce a strategic Marketing agreement. The joint partnership aims to advance the development of in vitro assay systems by using human-relevant models in the early phase of drug ...

Phage therapy diagnostic platform in global fight against multidrug-resistant infections

Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project

23-Jan-2023 - Vésale Bioscience, a company in the research and development of solutions and treatments using phage therapy for multi-resistant infections, announces it has received €1.8M ($1.9M) in grants fromthe European Innovation Council (EIC) Accelerator Fund for its PhageDiag project, a phagogram using ...

European Innovation Council funds Dermagnostix with 2.5 million euros

Start-up has made it its mission to push back the diagnostic boundaries

06-Dec-2022 - Dermagnostix GmbH, a joint spin-off of Hahn-Schickard, Helmholtz Munich and Technical University of Munich, was one of 30 companies to qualify for a direct grant from the European Innovation Council (EIC) and will receive 2.5 million euros to bring its product portfolio to market under the new ...

Werfen to Acquire Immucor, Inc.

Expanding its Presence in Specialized Diagnostics

07-Nov-2022 - Werfen announced that it has agreed to acquire Immucor, Inc., from TPG. Immucor is a privately held corporation with a strong global presence in transfusion and transplant in vitro diagnostics, headquartered in Norcross, Georgia, USA. This acquisition will allow Werfen to expand its portfolio of ...

APIS Assay Technologies Ltd acquires startup Clickmer Systems, which is developing antibody alternative

27-Apr-2022 - The British company APIS Assay Technologies Ltd has acquired the University of Bonn's spin-off project Clickmer Systems, which was further developed at the Life Science Inkubator (LSI), for a single-digit million euro sum. The startup is developing clickmers as a synthetic alternative to ...

Animal-free safety testing of novel medicines, chemicals, and consumer products

Spin-off from the Leiden University Medical Center opens US office and production facility to accelerate growth

21-Mar-2022 - Toxys BV, a Dutch biotech company that offers a broad spectrum of innovative in vitro toxicology solutions for the safety assessment of novel medicines, (agro)chemicals, cosmetics, and food ingredients, announces the opening of a sales office in New York (NY) and a production facility in ...

Medix Biochemica acquires myPOLS Biotec

All founders of myPOLS Biotec will remain involved in the business following the acquisition

07-Feb-2022 - Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH. As a result of the acquisition, Medix Biochemica broadens its portfolio of molecular diagnostic raw materials for the in vitro diagnostics (“IVD”) industry, complements its scientific expertise and strengthens its ...

Tecan successfully completes the acquisition of Paramit

05-Aug-2021 - The Tecan Group announced that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan entered into a definitive agreement to acquire ...

PerkinElmer to Acquire In-Vitro Diagnostics Company

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment

19-May-2021 - PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC (IDS) announced that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million). The transaction has a total enterprise value of ...